BNET Industries
- Private
Contact Information
NAICS Code Colleges, Universities, and Professional Schools: 611310
Recent Events
-
Mirna garners $5 million state grant
-
IMUC signs option agreement with MD Anderson Cancer Center
-
UTSA adopts Click Commerce’s research, compliance software
-
Sole Finalist Named for UTPA President Position
-
Collaboration creates 250 jobs in Richardson
-
Tech research at UT in line for $2M in funding
-
University of Texas at Dallas receives 16 gifts worth more than $16.8M
-
RF Code Announces First Ever Wire-Free Liquid Detection Sensor
-
In the race to turn back the biological clock, consumers are reaching for an unproven...
-
TerraTherm, Inc.: TerraTherm Royalty Payments to The University of Texas at Austin Top $1 Million...
News & Analysis
Filter by
finance and financial and university of texas - All News and Analysis
LifeCell Corporation
LifeCell Corporation 1 Millennium Way Branchburg, New Jersey 08876 U.S.A. Telephone: (908) 947-1100 Toll Free: (800) 367-5737 Fax: (908) 947-1200 Web site: http://www.lifecell.com Public Company Incorporated: 1986 Employees: 196 Sales: $61.1 million (2004) Stock Exchanges: NASDAQ Ticker Symbol: LIFC ...
Cephalon ends Parkinson's study early, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas.
M2 PRESSWIRE-12 May 2005-US Financial Network: Cephalon ends Parkinson's study early, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:12052005 City of Industry, CA -...
EDO Corp. acquires EVI Technology , U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas.
M2 PRESSWIRE-12 May 2005-US Financial Network: EDO Corp. acquires EVI Technology , U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:12052005 City of Industry, CA...
Angiotech Pharmaceuticals to participate in Banc of America Health Care Conference 2005, U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas.
M2 PRESSWIRE-12 May 2005-US Financial Network: Angiotech Pharmaceuticals to participate in Banc of America Health Care Conference 2005, U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:12052005...
FLIR Systems elects General William W. Crouch -U.S. Army, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas.
M2 PRESSWIRE-11 May 2005-US Financial Network: FLIR Systems elects General William W. Crouch -U.S. Army, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 City...
U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas, Forest Laboratories to buy back 25M shares.
M2 PRESSWIRE-11 May 2005-US Financial Network: U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas, Forest Laboratories to buy back 25M sharesC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 City of Industry,...
U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas, Arena Pharmaceuticals Shares Rise on Study Results.
M2 PRESSWIRE-11 May 2005-US Financial Network: U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas, Arena Pharmaceuticals Shares Rise on Study ResultsC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 City of...
U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas, General Dynamics Awarded $51 Million.
M2 PRESSWIRE-11 May 2005-US Financial Network: U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas, General Dynamics Awarded $51 MillionC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 City of Industry, CA -...
Statement Of Cash Flows
Statement of Cash Flows SCF is the financial document detailing the exchange of cash between a business and the outside world. It contains details about the cash coming in the organization through the activities of operations and finance. SCF also elaborates on the cash going out of the organization through...
Southern Union Company Names Corporate Officers
Business Editors AUSTIN, Texas--BUSINESS WIRE--Dec. 12, 2001 Southern Union Company ("Southern Union") (NYSE:SUG) announces the appointment of three corporate officers. Andre C. "Butch" Bouchard is named vice president - legal, Steve D. McGregor is named vice president - tax, and Jonathan A. Graf is named controller of Southern...
- 1
- 2
IndustryTop Rated
- Google Offers Free Downloads of a Million Books 11 votes
- InsideView Disrupts Legacy Business Info Publishers Like Hoover's 9 votes
- Mobile is the New Mass Medium, For Better or Worse 8 votes
- As Income Mobility Falls, American Dream Fades 7 votes
- E-Book Publisher Smashwords Partners with Barnes & Noble 6 votes


